Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Recent & Breaking News (TSXV:VIV)

Canadian Investment Regulatory Organization Trading Halt - VIV

Canada NewsWire March 6, 2024

Avivagen Announces New 500Kg Order for OxC-beta(TM)

Business Wire October 17, 2023

Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2023

Business Wire September 29, 2023

Avivagen Provides Corporate Updates

Business Wire July 31, 2023

Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta(TM) Livestock Product

Business Wire July 24, 2023

Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2023

Business Wire June 6, 2023

Avivagen Announces Significant Increase in Sales to an Existing Customer

Business Wire May 25, 2023

Avivagen Announces Review of Strategic Alternatives

Business Wire May 18, 2023

Avivagen Announces AGM Results

Business Wire April 19, 2023

Avivagen Inc. Provides Update on Securities for Service Agreements With CEO and CSO

Business Wire March 28, 2023

Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2023

Business Wire March 16, 2023

Avivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate Growth

Business Wire February 21, 2023

Avivagen Announces Foundational Scientific and Commercial Evidence of OxC-Beta(TM) Product Published in Peer-Reviewed Journal

Business Wire January 19, 2023

Avivagen Inc. Announces Securities for Service Agreements With CEO and CSO

Business Wire December 22, 2022

Avivagen Inc. Announces Closing of Second Tranche of a Private Placement of Shares

Business Wire October 31, 2022

Avivagen Inc. Announces Closing of First Tranche of a Non-Brokered Private Placement of Shares for Proceeds of up to $1.0 Million

Business Wire October 21, 2022

Avivagen Inc. Announces Proposed Non-Brokered Private Placement of Common Shares for Proceeds of up to $1.0 Million

Business Wire October 14, 2022

Avivagen (TSXV:VIV) announces financial results for Q2, 2022

Shoran Devi September 16, 2022

Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2022

Business Wire September 16, 2022

Avivagen Announces Publication of Peer-Reviewed Article in Food and Chemical Toxicology Journal

Business Wire September 7, 2022